Literature DB >> 31594171

[Chinese consensus of early colorectal cancer screening (2019, Shanghai)].

.   

Abstract

The patients with colorectal cancer in Chinese population are increasing, which is a serious threat to human life and health. In order to improve the high incidence, high mortality and low early diagnosis rate of colorectal cancer and promote cancer screening program in China, leading by the National Clinical Research Center for Digestive Disease (Shanghai), relying on Gastrointestinal-Cancer Prevention & Treatment Center Alliance, in conjunction with a number of related societies, we organized multidisciplinary experts including gastroenterology, digestive endoscopy, oncology, health management and endoscopic quality control to jointly develop this consensus. This consensus aims to establish and refine early colorectal cancer screening protocol adapting to our national conditions and guide the screening practice.

Entities:  

Keywords:  Colorectal neoplasms; Early diagnosis; Expert consensus; Screening

Mesh:

Year:  2019        PMID: 31594171     DOI: 10.3760/cma.j.issn.0578-1426.2019.10.004

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN: 0578-1426


  7 in total

1.  Prognosis model of colorectal cancer patients based on NOTCH3, KMT2C, and CREBBP mutations.

Authors:  Kai Liu; Jie-Fu Wang; Yang Zhan; Da-Lu Kong; Cui Wang
Journal:  J Gastrointest Oncol       Date:  2021-02

2.  Rectal Cancer in West China: Younger Onset, Poor Survival, and Poor Compliance.

Authors:  Chao Fang; Lie Yang; Yongyang Yu; Cun Wang; Zongguang Zhou
Journal:  Dis Colon Rectum       Date:  2021-06-01       Impact factor: 4.585

3.  Comparative yield and efficiency of strategies based on risk assessment and fecal immunochemical test in colorectal cancer screening: A cross-sectional population-based analysis.

Authors:  Hongda Chen; Le Wang; Ming Lu; Chen Zhu; Yunfeng Zhu; Weihua Ma; Xinmin Chen; Lingbin Du; Wanqing Chen
Journal:  Chin J Cancer Res       Date:  2021-08-31       Impact factor: 5.087

4.  A Novel Stool Methylation Test for the Non-Invasive Screening of Gastric and Colorectal Cancer.

Authors:  Liang Ma; Jian Gong; Meimei Zhao; Xiaomu Kong; Peng Gao; Yongwei Jiang; Yi Liu; Xiaoyan Feng; Shuang Si; Yongtong Cao
Journal:  Front Oncol       Date:  2022-03-28       Impact factor: 6.244

5.  Quantification of fibrinogen-to-pre-albumin ratio provides an integrating parameter for differential diagnosis and risk stratification of early-stage colorectal cancer.

Authors:  Hou-Qun Ying; Wei Chen; Cui-Fen Xiong; Yuanyuan Wang; Xiao-Juan Li; Xue-Xin Cheng
Journal:  Cancer Cell Int       Date:  2022-03-27       Impact factor: 5.722

6.  Colorectal Cancer Screening in China: Status, Challenges, and Prospects - China, 2022.

Authors:  Hongda Chen; Bin Lu; Min Dai
Journal:  China CDC Wkly       Date:  2022-04-15

7.  External validation of models for predicting risk of colorectal cancer using the China Kadoorie Biobank.

Authors:  Roxanna E Abhari; Blake Thomson; Ling Yang; Iona Millwood; Yu Guo; Xiaoming Yang; Jun Lv; Daniel Avery; Pei Pei; Peng Wen; Canqing Yu; Yiping Chen; Junshi Chen; Liming Li; Zhengming Chen; Christiana Kartsonaki
Journal:  BMC Med       Date:  2022-09-08       Impact factor: 11.150

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.